<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02328339</url>
  </required_header>
  <id_info>
    <org_study_id>REF-BEV-1797</org_study_id>
    <nct_id>NCT02328339</nct_id>
  </id_info>
  <brief_title>Tea and Forearm Blood Flow</brief_title>
  <official_title>Forearm Blood Flow Response to Acute Consumption of Black Tea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Unilever R&amp;D</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will explore the benefit of tea for microcirculation. Subjects will consume tea ar&#xD;
      a placebo matched for taste and appearance in a blinded cross over design.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidemiological studies indicate that regular consumption of black tea reduces the risk of&#xD;
      cardiovascular diseases. Tea consumption can result in improvements in endothelial function&#xD;
      of conduit arteries as measured by flow mediated dilation.&#xD;
&#xD;
      Less is known however about its effects in other vascular beds. The study will test the&#xD;
      hypothesis that tea affects endothelial function in the muscle microcirculation. This will be&#xD;
      done by assessment of forearm blood flow using venous occlusion plethysmography after&#xD;
      consumption of black tea against or placebo in a randomised, full cross-over study in 20&#xD;
      healthy middle-aged to elderly subjects&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forearm blood flow response to acetylcholine</measure>
    <time_frame>During acetylcholine infusion 120-140 min after first tea/placebo intake</time_frame>
    <description>Does tea ingestion change mean forearm blood flow response to acetylcholine when compared to placebo</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Forearm blood flow response to sodium nitropusside</measure>
    <time_frame>During sodium nitropusside infusion 170-190 min after first tea/placebo intake</time_frame>
    <description>Does tea ingestion change mean forearm blood flow response to sodium nitropusside when compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forearm blood flow response to L-NMMA</measure>
    <time_frame>During L-NMMA infusion 220-240 min after first tea/placebo intake</time_frame>
    <description>Does tea ingestion change mean forearm blood flow response to L-NG-monomethyl Arginine (L-NMMA) when compared to placebo</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Vascular Function</condition>
  <arm_group>
    <arm_group_label>Black tea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Approximately 400 mg total polyphenols in 240 ml hot water (loading dose; 2 hours before the start of measurements; t=0) and 130 mg total polyphenols in 120 ml hot water (maintenance dose just before start of the measurements; t=120 min)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Caramel colour, maltodextrin and tea flavour in 240 ml hot water (2 hours before the start of measurements; t=0) and 120 ml hot water (maintenance dose just before start of the measurements; t=120 min)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tea</intervention_name>
    <description>Black tea infusion equivalent to approximately 530 mg total polyphenols expressed as gallic acid equivalents</description>
    <arm_group_label>Black tea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo matched to tea with respect to taste and appearance</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and post menopausal (&gt; 1 years) females&#xD;
&#xD;
          -  Aged ≥ 45 and ≤ 75 years&#xD;
&#xD;
          -  Body mass index (BMI) of ≥ 18.0 and ≤ 35.0 kg/m2&#xD;
&#xD;
          -  Judged to be in good health on the basis of medical history, physical examination and&#xD;
             routine laboratory tests (total cholesterol, HDL cholesterol, LDL cholesterol,&#xD;
             triglycerides, glucose, highly sensitive C-reactive protein).&#xD;
&#xD;
          -  Normal blood coagulation as assessed by routine lab tests&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Strenuous exercise &gt; 2 hours per week. Strenuous exercise is defined as exercise which&#xD;
             induces sweating and causes sufficient breathlessness to limit conversation&#xD;
&#xD;
          -  Current smoker or has stopped smoking less than 6 months before start of study&#xD;
&#xD;
          -  Self reported alcohol intake of &gt; 21 units/week)&#xD;
&#xD;
          -  Established cardiovascular disease or clinically significant arrhythmia&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Blood pressure &gt; 160/100 mmHg&#xD;
&#xD;
          -  Taking medication that might affect endothelial function (as judged by the PI)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sean Roerink, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>December 19, 2014</study_first_submitted>
  <study_first_submitted_qc>December 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2014</study_first_posted>
  <last_update_submitted>August 28, 2015</last_update_submitted>
  <last_update_submitted_qc>August 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

